Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids.

Article Details

Citation
Copy to clipboard

Squadrito F, Altavilla D, Oliaro Bosso S

Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids.

Eur Rev Med Pharmacol Sci. 2000 Jan-Apr;4(1-2):21-4.

PubMed ID
11409185 [ View in PubMed
]
Abstract

This multicenter, double-blind, randomised study was undertaken to determine the efficacy and safety of a combination of troxerutin 150 mg and carbazochrome 1.5 mg compared to carbazochrome alone in patients with acute uncomplicated hemorrhoids. Patients were administered by the intramuscular route (one ampoule) twice daily for one week. Both subjective and objective efficacy variables significantly improved in the combination drug group only, thus demonstrating the rationale for a combination therapy. Treatments were safe and well tolerated either at a local or systemic level.

DrugBank Data that Cites this Article

Drugs